Skip to content
Search

Latest Stories

Community Pharmacy England seeks pharmacy owners view ahead of its committee meeting

The Community Pharmacy England Committee has adopted a new approach to engagement with sector by inviting all pharmacy owners to share their views on pharmacy’s finances, pressures and capacity ahead of its meeting in July.

It has sought views of pharmacists via short poll by Sunday (2 July) and will have a discussion on the poll results at the meeting before reporting back to the sector afterwards.


The key focus for July Committee Meeting will be to make most of £645m for the community pharmacy sector, and also on the ongoing work to make the wider case for more investment in the sector.

This new way of working follows association's rebrand on 30th May which signalled the start of its new approach to engagement to help them to build stronger relationships with pharmacy owners.

The association hopes this new approach will help them better engage with members and listen to pharmacy’s views better.

Survey for July’s Meeting

To help make the feedback process easier for busy pharmacy owners, we have developed a series of polls to gauge your thoughts on topical issues. The short survey of mostly multiple-choice questions should take around 10 minutes to complete.

For the July meeting, we are keen to hear your views on your pharmacy’s finances, pressures and capacity. In particular, we want to know how your business is coping financially, the impact the current economic situation is having on the care you can provide patients, your capacity to offer advanced services, and what changes (other than funding) would make your life easier.

Beyond this, there is also space to add additional feedback should you have more to share, and a section where you can tell us what other topics we should collect pharmacy owners’ thoughts on.

Note, this survey is for community pharmacy owners and head office representatives only.

Janet Morrison, Chief Executive of Community Pharmacy England, said: “We are now in the middle of critical negotiations to make sure that community pharmacies benefit as much as possible from the £645m investment that was promised to the sector as part of the Government’s Primary Care Access Plan. We are also continuing to highlight the immense pressures on the sector and to press for further support and investment in the sector.

"This critical work will clearly be the focus of our upcoming Committee Meeting, but we have also ringfenced time at the Committee to reflect on what we are hearing from all of you, as the pharmacy owners we represent. As the voice of community pharmacy, we want to collaborate even more with our members across the sector. Our new pre-Committee Meeting polling offers the chance for all pharmacy owners to tell us about their reflections, primary concerns and challenges, as well as their ideas for future polling.

"The results of this poll will help us to listen to and to better represent your views, and the data we gather will also help us to get our key messages across to Ministers, officials and other policymakers. There is a real commitment from everyone here to shift the ways in which we engage with you, and in time we hope these surveys will become a really valuable tool in delivering your thoughts directly to our Committee, and beyond.

I’m conscious that this is yet another survey, but the more we hear from you the more powerfully we can represent your views to Government, so I hope you will be able to find ten minutes to complete the survey. You can also use it to let us know if you would rather we engaged with you in other ways in the future, or to flag other key issues – whatever you are able to share, we’ll be listening.”

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less